nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—ADRA2C—Methamphetamine—obesity	0.124	0.186	CbGbCtD
Tizanidine—ADRA2B—Methamphetamine—obesity	0.118	0.177	CbGbCtD
Tizanidine—ADRA2A—Benzphetamine—obesity	0.102	0.154	CbGbCtD
Tizanidine—ADRA2A—Phenylpropanolamine—obesity	0.0977	0.147	CbGbCtD
Tizanidine—ADRA2A—Methamphetamine—obesity	0.0818	0.123	CbGbCtD
Tizanidine—CYP1A2—Phentermine—obesity	0.0413	0.0621	CbGbCtD
Tizanidine—CYP1A2—Phenylpropanolamine—obesity	0.0394	0.0593	CbGbCtD
Tizanidine—CYP1A2—Bupropion—obesity	0.0351	0.0528	CbGbCtD
Tizanidine—CYP1A2—Cimetidine—obesity	0.0258	0.0388	CbGbCtD
Tizanidine—Clonidine—SLC22A1—obesity	0.000598	1	CrCbGaD
Tizanidine—NISCH—islet of Langerhans—obesity	0.000581	0.13	CbGeAlD
Tizanidine—NISCH—adrenal cortex—obesity	0.00046	0.103	CbGeAlD
Tizanidine—NISCH—pituitary gland—obesity	0.000372	0.0831	CbGeAlD
Tizanidine—NISCH—adipose tissue—obesity	0.000371	0.0828	CbGeAlD
Tizanidine—NISCH—adrenal gland—obesity	0.000332	0.0742	CbGeAlD
Tizanidine—NISCH—liver—obesity	0.00026	0.058	CbGeAlD
Tizanidine—CYP1A2—respiratory system—obesity	0.000217	0.0486	CbGeAlD
Tizanidine—ADRA2A—islet of Langerhans—obesity	0.000212	0.0473	CbGeAlD
Tizanidine—ADRA2C—adrenal cortex—obesity	0.00021	0.047	CbGeAlD
Tizanidine—Tension—Sibutramine—obesity	0.0002	0.000914	CcSEcCtD
Tizanidine—Vision blurred—Orlistat—obesity	0.000198	0.000907	CcSEcCtD
Tizanidine—Nervousness—Sibutramine—obesity	0.000198	0.000904	CcSEcCtD
Tizanidine—Vomiting—Cimetidine—obesity	0.000198	0.000904	CcSEcCtD
Tizanidine—Back pain—Sibutramine—obesity	0.000197	0.000901	CcSEcCtD
Tizanidine—Rash—Cimetidine—obesity	0.000196	0.000897	CcSEcCtD
Tizanidine—Dermatitis—Cimetidine—obesity	0.000196	0.000896	CcSEcCtD
Tizanidine—Muscle spasms—Sibutramine—obesity	0.000196	0.000895	CcSEcCtD
Tizanidine—Ill-defined disorder—Orlistat—obesity	0.000195	0.000893	CcSEcCtD
Tizanidine—Purpura—Topiramate—obesity	0.000195	0.000891	CcSEcCtD
Tizanidine—Nausea—Diethylpropion—obesity	0.000194	0.000888	CcSEcCtD
Tizanidine—Erythema multiforme—Bupropion—obesity	0.000193	0.000882	CcSEcCtD
Tizanidine—Vision blurred—Sibutramine—obesity	0.000192	0.000878	CcSEcCtD
Tizanidine—Tremor—Sibutramine—obesity	0.000191	0.000873	CcSEcCtD
Tizanidine—Tinnitus—Bupropion—obesity	0.00019	0.00087	CcSEcCtD
Tizanidine—Malaise—Orlistat—obesity	0.00019	0.000868	CcSEcCtD
Tizanidine—Cardiac disorder—Bupropion—obesity	0.000189	0.000866	CcSEcCtD
Tizanidine—Vertigo—Orlistat—obesity	0.000189	0.000865	CcSEcCtD
Tizanidine—Ill-defined disorder—Sibutramine—obesity	0.000189	0.000864	CcSEcCtD
Tizanidine—Hyponatraemia—Topiramate—obesity	0.000189	0.000862	CcSEcCtD
Tizanidine—Anaemia—Sibutramine—obesity	0.000188	0.000861	CcSEcCtD
Tizanidine—Agitation—Sibutramine—obesity	0.000187	0.000856	CcSEcCtD
Tizanidine—Angiopathy—Bupropion—obesity	0.000185	0.000846	CcSEcCtD
Tizanidine—Affect lability—Topiramate—obesity	0.000185	0.000845	CcSEcCtD
Tizanidine—Migraine—Topiramate—obesity	0.000185	0.000845	CcSEcCtD
Tizanidine—Nausea—Cimetidine—obesity	0.000185	0.000845	CcSEcCtD
Tizanidine—Immune system disorder—Bupropion—obesity	0.000184	0.000842	CcSEcCtD
Tizanidine—Mediastinal disorder—Bupropion—obesity	0.000184	0.000841	CcSEcCtD
Tizanidine—Malaise—Sibutramine—obesity	0.000184	0.00084	CcSEcCtD
Tizanidine—Psychotic disorder—Topiramate—obesity	0.000184	0.000839	CcSEcCtD
Tizanidine—Vertigo—Sibutramine—obesity	0.000183	0.000837	CcSEcCtD
Tizanidine—Syncope—Sibutramine—obesity	0.000183	0.000835	CcSEcCtD
Tizanidine—Convulsion—Orlistat—obesity	0.000182	0.000834	CcSEcCtD
Tizanidine—Leukopenia—Sibutramine—obesity	0.000182	0.000834	CcSEcCtD
Tizanidine—Arrhythmia—Bupropion—obesity	0.000182	0.000833	CcSEcCtD
Tizanidine—Alopecia—Bupropion—obesity	0.00018	0.000824	CcSEcCtD
Tizanidine—Loss of consciousness—Sibutramine—obesity	0.000179	0.000819	CcSEcCtD
Tizanidine—Mental disorder—Bupropion—obesity	0.000179	0.000817	CcSEcCtD
Tizanidine—Urinary retention—Topiramate—obesity	0.000179	0.000817	CcSEcCtD
Tizanidine—Anxiety—Orlistat—obesity	0.000179	0.000816	CcSEcCtD
Tizanidine—Mood swings—Topiramate—obesity	0.000178	0.000814	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000178	0.000814	CcSEcCtD
Tizanidine—Discomfort—Orlistat—obesity	0.000177	0.000809	CcSEcCtD
Tizanidine—Convulsion—Sibutramine—obesity	0.000177	0.000807	CcSEcCtD
Tizanidine—Hypertension—Sibutramine—obesity	0.000176	0.000804	CcSEcCtD
Tizanidine—Dry mouth—Orlistat—obesity	0.000175	0.000801	CcSEcCtD
Tizanidine—Flatulence—Bupropion—obesity	0.000175	0.0008	CcSEcCtD
Tizanidine—Tension—Bupropion—obesity	0.000174	0.000797	CcSEcCtD
Tizanidine—Liver function test abnormal—Topiramate—obesity	0.000174	0.000793	CcSEcCtD
Tizanidine—Arthralgia—Sibutramine—obesity	0.000173	0.000793	CcSEcCtD
Tizanidine—Anxiety—Sibutramine—obesity	0.000173	0.00079	CcSEcCtD
Tizanidine—Nervousness—Bupropion—obesity	0.000173	0.000789	CcSEcCtD
Tizanidine—Anaphylactic shock—Orlistat—obesity	0.000172	0.000785	CcSEcCtD
Tizanidine—Oedema—Orlistat—obesity	0.000172	0.000785	CcSEcCtD
Tizanidine—Back pain—Bupropion—obesity	0.000172	0.000785	CcSEcCtD
Tizanidine—Orthostatic hypotension—Topiramate—obesity	0.000172	0.000784	CcSEcCtD
Tizanidine—Discomfort—Sibutramine—obesity	0.000171	0.000783	CcSEcCtD
Tizanidine—Hypokalaemia—Topiramate—obesity	0.000171	0.000782	CcSEcCtD
Tizanidine—Muscle spasms—Bupropion—obesity	0.000171	0.000781	CcSEcCtD
Tizanidine—Infection—Orlistat—obesity	0.000171	0.00078	CcSEcCtD
Tizanidine—ADRA2C—pituitary gland—obesity	0.00017	0.038	CbGeAlD
Tizanidine—Dry mouth—Sibutramine—obesity	0.00017	0.000775	CcSEcCtD
Tizanidine—ADRA2C—adipose tissue—obesity	0.000169	0.0378	CbGeAlD
Tizanidine—Nervous system disorder—Orlistat—obesity	0.000169	0.00077	CcSEcCtD
Tizanidine—Confusional state—Sibutramine—obesity	0.000168	0.000766	CcSEcCtD
Tizanidine—Vision blurred—Bupropion—obesity	0.000167	0.000765	CcSEcCtD
Tizanidine—Skin disorder—Orlistat—obesity	0.000167	0.000763	CcSEcCtD
Tizanidine—Tremor—Bupropion—obesity	0.000166	0.000761	CcSEcCtD
Tizanidine—Oedema—Sibutramine—obesity	0.000166	0.00076	CcSEcCtD
Tizanidine—Anaphylactic shock—Sibutramine—obesity	0.000166	0.00076	CcSEcCtD
Tizanidine—Hyperhidrosis—Orlistat—obesity	0.000166	0.000759	CcSEcCtD
Tizanidine—Muscular weakness—Topiramate—obesity	0.000166	0.000758	CcSEcCtD
Tizanidine—Alanine aminotransferase increased—Topiramate—obesity	0.000166	0.000758	CcSEcCtD
Tizanidine—Infection—Sibutramine—obesity	0.000165	0.000755	CcSEcCtD
Tizanidine—Ill-defined disorder—Bupropion—obesity	0.000165	0.000753	CcSEcCtD
Tizanidine—Anaemia—Bupropion—obesity	0.000164	0.00075	CcSEcCtD
Tizanidine—Shock—Sibutramine—obesity	0.000164	0.000748	CcSEcCtD
Tizanidine—Agitation—Bupropion—obesity	0.000163	0.000746	CcSEcCtD
Tizanidine—Thrombocytopenia—Sibutramine—obesity	0.000163	0.000744	CcSEcCtD
Tizanidine—Dysphagia—Topiramate—obesity	0.000162	0.000742	CcSEcCtD
Tizanidine—Asthma—Topiramate—obesity	0.000162	0.000742	CcSEcCtD
Tizanidine—Tachycardia—Sibutramine—obesity	0.000162	0.000742	CcSEcCtD
Tizanidine—Skin disorder—Sibutramine—obesity	0.000162	0.000738	CcSEcCtD
Tizanidine—Hyperhidrosis—Sibutramine—obesity	0.000161	0.000735	CcSEcCtD
Tizanidine—Malaise—Bupropion—obesity	0.00016	0.000732	CcSEcCtD
Tizanidine—Vertigo—Bupropion—obesity	0.00016	0.000729	CcSEcCtD
Tizanidine—Syncope—Bupropion—obesity	0.000159	0.000728	CcSEcCtD
Tizanidine—Leukopenia—Bupropion—obesity	0.000159	0.000727	CcSEcCtD
Tizanidine—Angina pectoris—Topiramate—obesity	0.000158	0.000723	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Orlistat—obesity	0.000157	0.000716	CcSEcCtD
Tizanidine—Bronchitis—Topiramate—obesity	0.000156	0.000714	CcSEcCtD
Tizanidine—Loss of consciousness—Bupropion—obesity	0.000156	0.000714	CcSEcCtD
Tizanidine—Hypotension—Sibutramine—obesity	0.000155	0.00071	CcSEcCtD
Tizanidine—Paraesthesia—Orlistat—obesity	0.000154	0.000705	CcSEcCtD
Tizanidine—Convulsion—Bupropion—obesity	0.000154	0.000703	CcSEcCtD
Tizanidine—Hypertension—Bupropion—obesity	0.000153	0.000701	CcSEcCtD
Tizanidine—ADRA2C—adrenal gland—obesity	0.000152	0.0339	CbGeAlD
Tizanidine—Musculoskeletal discomfort—Sibutramine—obesity	0.000152	0.000692	CcSEcCtD
Tizanidine—Dyspepsia—Orlistat—obesity	0.000151	0.000691	CcSEcCtD
Tizanidine—Arthralgia—Bupropion—obesity	0.000151	0.000691	CcSEcCtD
Tizanidine—Anxiety—Bupropion—obesity	0.000151	0.000689	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.00015	0.000686	CcSEcCtD
Tizanidine—Pollakiuria—Topiramate—obesity	0.00015	0.000686	CcSEcCtD
Tizanidine—Discomfort—Bupropion—obesity	0.000149	0.000683	CcSEcCtD
Tizanidine—Paraesthesia—Sibutramine—obesity	0.000149	0.000682	CcSEcCtD
Tizanidine—Dyspnoea—Sibutramine—obesity	0.000148	0.000678	CcSEcCtD
Tizanidine—Fatigue—Orlistat—obesity	0.000148	0.000677	CcSEcCtD
Tizanidine—Dry mouth—Bupropion—obesity	0.000148	0.000676	CcSEcCtD
Tizanidine—Somnolence—Sibutramine—obesity	0.000148	0.000676	CcSEcCtD
Tizanidine—Weight decreased—Topiramate—obesity	0.000147	0.000672	CcSEcCtD
Tizanidine—Hyperglycaemia—Topiramate—obesity	0.000147	0.00067	CcSEcCtD
Tizanidine—Dyspepsia—Sibutramine—obesity	0.000146	0.000669	CcSEcCtD
Tizanidine—Confusional state—Bupropion—obesity	0.000146	0.000668	CcSEcCtD
Tizanidine—Pneumonia—Topiramate—obesity	0.000146	0.000666	CcSEcCtD
Tizanidine—Oedema—Bupropion—obesity	0.000145	0.000663	CcSEcCtD
Tizanidine—Anaphylactic shock—Bupropion—obesity	0.000145	0.000663	CcSEcCtD
Tizanidine—Depression—Topiramate—obesity	0.000144	0.00066	CcSEcCtD
Tizanidine—Infection—Bupropion—obesity	0.000144	0.000658	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Topiramate—obesity	0.000144	0.000656	CcSEcCtD
Tizanidine—Shock—Bupropion—obesity	0.000143	0.000652	CcSEcCtD
Tizanidine—Renal failure—Topiramate—obesity	0.000142	0.000651	CcSEcCtD
Tizanidine—Constipation—Sibutramine—obesity	0.000142	0.00065	CcSEcCtD
Tizanidine—Nervous system disorder—Bupropion—obesity	0.000142	0.00065	CcSEcCtD
Tizanidine—Neuropathy peripheral—Topiramate—obesity	0.000142	0.000649	CcSEcCtD
Tizanidine—Thrombocytopenia—Bupropion—obesity	0.000142	0.000649	CcSEcCtD
Tizanidine—Feeling abnormal—Orlistat—obesity	0.000142	0.000647	CcSEcCtD
Tizanidine—Tachycardia—Bupropion—obesity	0.000141	0.000647	CcSEcCtD
Tizanidine—Skin disorder—Bupropion—obesity	0.000141	0.000644	CcSEcCtD
Tizanidine—Conjunctivitis—Topiramate—obesity	0.000141	0.000643	CcSEcCtD
Tizanidine—Gastrointestinal pain—Orlistat—obesity	0.000141	0.000642	CcSEcCtD
Tizanidine—Hyperhidrosis—Bupropion—obesity	0.00014	0.000641	CcSEcCtD
Tizanidine—CYP1A2—digestive system—obesity	0.000138	0.0309	CbGeAlD
Tizanidine—Haematuria—Topiramate—obesity	0.000138	0.000631	CcSEcCtD
Tizanidine—Feeling abnormal—Sibutramine—obesity	0.000137	0.000626	CcSEcCtD
Tizanidine—Urticaria—Orlistat—obesity	0.000137	0.000624	CcSEcCtD
Tizanidine—Gastrointestinal pain—Sibutramine—obesity	0.000136	0.000622	CcSEcCtD
Tizanidine—Sinusitis—Topiramate—obesity	0.000136	0.000621	CcSEcCtD
Tizanidine—Body temperature increased—Orlistat—obesity	0.000136	0.000621	CcSEcCtD
Tizanidine—Abdominal pain—Orlistat—obesity	0.000136	0.000621	CcSEcCtD
Tizanidine—ADRA2A—pituitary gland—obesity	0.000136	0.0303	CbGeAlD
Tizanidine—Hypotension—Bupropion—obesity	0.000135	0.000619	CcSEcCtD
Tizanidine—Agranulocytosis—Topiramate—obesity	0.000135	0.000618	CcSEcCtD
Tizanidine—ADRA2A—adipose tissue—obesity	0.000135	0.0302	CbGeAlD
Tizanidine—Bradycardia—Topiramate—obesity	0.000132	0.000605	CcSEcCtD
Tizanidine—Urticaria—Sibutramine—obesity	0.000132	0.000604	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Bupropion—obesity	0.000132	0.000604	CcSEcCtD
Tizanidine—Abdominal pain—Sibutramine—obesity	0.000131	0.000601	CcSEcCtD
Tizanidine—Body temperature increased—Sibutramine—obesity	0.000131	0.000601	CcSEcCtD
Tizanidine—Haemoglobin—Topiramate—obesity	0.000131	0.000597	CcSEcCtD
Tizanidine—Rhinitis—Topiramate—obesity	0.00013	0.000596	CcSEcCtD
Tizanidine—Paraesthesia—Bupropion—obesity	0.00013	0.000595	CcSEcCtD
Tizanidine—Haemorrhage—Topiramate—obesity	0.00013	0.000594	CcSEcCtD
Tizanidine—Hepatitis—Topiramate—obesity	0.00013	0.000594	CcSEcCtD
Tizanidine—Hallucination—Topiramate—obesity	0.000129	0.000591	CcSEcCtD
Tizanidine—Dyspnoea—Bupropion—obesity	0.000129	0.000591	CcSEcCtD
Tizanidine—Pharyngitis—Topiramate—obesity	0.000129	0.00059	CcSEcCtD
Tizanidine—Somnolence—Bupropion—obesity	0.000129	0.000589	CcSEcCtD
Tizanidine—Urinary tract disorder—Topiramate—obesity	0.000128	0.000587	CcSEcCtD
Tizanidine—Connective tissue disorder—Topiramate—obesity	0.000128	0.000584	CcSEcCtD
Tizanidine—Dyspepsia—Bupropion—obesity	0.000128	0.000583	CcSEcCtD
Tizanidine—Urethral disorder—Topiramate—obesity	0.000127	0.000582	CcSEcCtD
Tizanidine—Hypersensitivity—Orlistat—obesity	0.000127	0.000579	CcSEcCtD
Tizanidine—Fatigue—Bupropion—obesity	0.000125	0.000571	CcSEcCtD
Tizanidine—Constipation—Bupropion—obesity	0.000124	0.000567	CcSEcCtD
Tizanidine—Asthenia—Orlistat—obesity	0.000123	0.000563	CcSEcCtD
Tizanidine—Erythema multiforme—Topiramate—obesity	0.000123	0.000562	CcSEcCtD
Tizanidine—Hypersensitivity—Sibutramine—obesity	0.000123	0.00056	CcSEcCtD
Tizanidine—Pruritus—Orlistat—obesity	0.000122	0.000556	CcSEcCtD
Tizanidine—Tinnitus—Topiramate—obesity	0.000121	0.000554	CcSEcCtD
Tizanidine—ADRA2A—adrenal gland—obesity	0.000121	0.0271	CbGeAlD
Tizanidine—Cardiac disorder—Topiramate—obesity	0.000121	0.000551	CcSEcCtD
Tizanidine—Feeling abnormal—Bupropion—obesity	0.000119	0.000546	CcSEcCtD
Tizanidine—Asthenia—Sibutramine—obesity	0.000119	0.000545	CcSEcCtD
Tizanidine—ADRA2C—liver—obesity	0.000119	0.0265	CbGeAlD
Tizanidine—Gastrointestinal pain—Bupropion—obesity	0.000119	0.000542	CcSEcCtD
Tizanidine—Angiopathy—Topiramate—obesity	0.000118	0.000539	CcSEcCtD
Tizanidine—Pruritus—Sibutramine—obesity	0.000118	0.000538	CcSEcCtD
Tizanidine—Diarrhoea—Orlistat—obesity	0.000118	0.000537	CcSEcCtD
Tizanidine—Immune system disorder—Topiramate—obesity	0.000117	0.000537	CcSEcCtD
Tizanidine—Mediastinal disorder—Topiramate—obesity	0.000117	0.000536	CcSEcCtD
Tizanidine—Urticaria—Bupropion—obesity	0.000115	0.000526	CcSEcCtD
Tizanidine—Alopecia—Topiramate—obesity	0.000115	0.000525	CcSEcCtD
Tizanidine—Abdominal pain—Bupropion—obesity	0.000115	0.000524	CcSEcCtD
Tizanidine—Body temperature increased—Bupropion—obesity	0.000115	0.000524	CcSEcCtD
Tizanidine—CYP1A2—endocrine gland—obesity	0.000114	0.0255	CbGeAlD
Tizanidine—Mental disorder—Topiramate—obesity	0.000114	0.000521	CcSEcCtD
Tizanidine—Diarrhoea—Sibutramine—obesity	0.000114	0.00052	CcSEcCtD
Tizanidine—Dizziness—Orlistat—obesity	0.000114	0.000519	CcSEcCtD
Tizanidine—Flatulence—Topiramate—obesity	0.000112	0.00051	CcSEcCtD
Tizanidine—Tension—Topiramate—obesity	0.000111	0.000508	CcSEcCtD
Tizanidine—Dizziness—Sibutramine—obesity	0.00011	0.000503	CcSEcCtD
Tizanidine—Nervousness—Topiramate—obesity	0.00011	0.000502	CcSEcCtD
Tizanidine—Back pain—Topiramate—obesity	0.000109	0.0005	CcSEcCtD
Tizanidine—Vomiting—Orlistat—obesity	0.000109	0.000499	CcSEcCtD
Tizanidine—Muscle spasms—Topiramate—obesity	0.000109	0.000497	CcSEcCtD
Tizanidine—Rash—Orlistat—obesity	0.000108	0.000495	CcSEcCtD
Tizanidine—Dermatitis—Orlistat—obesity	0.000108	0.000495	CcSEcCtD
Tizanidine—Hypersensitivity—Bupropion—obesity	0.000107	0.000488	CcSEcCtD
Tizanidine—Vision blurred—Topiramate—obesity	0.000107	0.000487	CcSEcCtD
Tizanidine—Tremor—Topiramate—obesity	0.000106	0.000485	CcSEcCtD
Tizanidine—Vomiting—Sibutramine—obesity	0.000106	0.000483	CcSEcCtD
Tizanidine—ADRA2A—endocrine gland—obesity	0.000105	0.0235	CbGeAlD
Tizanidine—Ill-defined disorder—Topiramate—obesity	0.000105	0.00048	CcSEcCtD
Tizanidine—Rash—Sibutramine—obesity	0.000105	0.000479	CcSEcCtD
Tizanidine—Dermatitis—Sibutramine—obesity	0.000105	0.000479	CcSEcCtD
Tizanidine—Anaemia—Topiramate—obesity	0.000105	0.000478	CcSEcCtD
Tizanidine—Asthenia—Bupropion—obesity	0.000104	0.000475	CcSEcCtD
Tizanidine—Agitation—Topiramate—obesity	0.000104	0.000475	CcSEcCtD
Tizanidine—CYP1A2—liver—obesity	0.000103	0.023	CbGeAlD
Tizanidine—Pruritus—Bupropion—obesity	0.000103	0.000469	CcSEcCtD
Tizanidine—Nausea—Orlistat—obesity	0.000102	0.000466	CcSEcCtD
Tizanidine—Malaise—Topiramate—obesity	0.000102	0.000466	CcSEcCtD
Tizanidine—Vertigo—Topiramate—obesity	0.000102	0.000465	CcSEcCtD
Tizanidine—Syncope—Topiramate—obesity	0.000101	0.000464	CcSEcCtD
Tizanidine—Leukopenia—Topiramate—obesity	0.000101	0.000463	CcSEcCtD
Tizanidine—Loss of consciousness—Topiramate—obesity	9.95e-05	0.000455	CcSEcCtD
Tizanidine—Diarrhoea—Bupropion—obesity	9.92e-05	0.000453	CcSEcCtD
Tizanidine—Nausea—Sibutramine—obesity	9.88e-05	0.000451	CcSEcCtD
Tizanidine—Convulsion—Topiramate—obesity	9.81e-05	0.000448	CcSEcCtD
Tizanidine—Hypertension—Topiramate—obesity	9.77e-05	0.000447	CcSEcCtD
Tizanidine—Arthralgia—Topiramate—obesity	9.64e-05	0.00044	CcSEcCtD
Tizanidine—Anxiety—Topiramate—obesity	9.6e-05	0.000439	CcSEcCtD
Tizanidine—Dizziness—Bupropion—obesity	9.59e-05	0.000438	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	9.57e-05	0.000437	CcSEcCtD
Tizanidine—Discomfort—Topiramate—obesity	9.52e-05	0.000435	CcSEcCtD
Tizanidine—Dry mouth—Topiramate—obesity	9.42e-05	0.000431	CcSEcCtD
Tizanidine—Confusional state—Topiramate—obesity	9.31e-05	0.000426	CcSEcCtD
Tizanidine—Oedema—Topiramate—obesity	9.24e-05	0.000422	CcSEcCtD
Tizanidine—Vomiting—Bupropion—obesity	9.22e-05	0.000421	CcSEcCtD
Tizanidine—Infection—Topiramate—obesity	9.18e-05	0.000419	CcSEcCtD
Tizanidine—Rash—Bupropion—obesity	9.14e-05	0.000418	CcSEcCtD
Tizanidine—Dermatitis—Bupropion—obesity	9.13e-05	0.000417	CcSEcCtD
Tizanidine—Shock—Topiramate—obesity	9.09e-05	0.000415	CcSEcCtD
Tizanidine—Nervous system disorder—Topiramate—obesity	9.06e-05	0.000414	CcSEcCtD
Tizanidine—Thrombocytopenia—Topiramate—obesity	9.04e-05	0.000413	CcSEcCtD
Tizanidine—Tachycardia—Topiramate—obesity	9.01e-05	0.000412	CcSEcCtD
Tizanidine—Skin disorder—Topiramate—obesity	8.97e-05	0.00041	CcSEcCtD
Tizanidine—Hyperhidrosis—Topiramate—obesity	8.93e-05	0.000408	CcSEcCtD
Tizanidine—Hypotension—Topiramate—obesity	8.63e-05	0.000394	CcSEcCtD
Tizanidine—Nausea—Bupropion—obesity	8.61e-05	0.000394	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Topiramate—obesity	8.42e-05	0.000385	CcSEcCtD
Tizanidine—Paraesthesia—Topiramate—obesity	8.29e-05	0.000379	CcSEcCtD
Tizanidine—Dyspnoea—Topiramate—obesity	8.23e-05	0.000376	CcSEcCtD
Tizanidine—Somnolence—Topiramate—obesity	8.21e-05	0.000375	CcSEcCtD
Tizanidine—Dyspepsia—Topiramate—obesity	8.13e-05	0.000372	CcSEcCtD
Tizanidine—Fatigue—Topiramate—obesity	7.96e-05	0.000364	CcSEcCtD
Tizanidine—Constipation—Topiramate—obesity	7.9e-05	0.000361	CcSEcCtD
Tizanidine—Feeling abnormal—Topiramate—obesity	7.61e-05	0.000348	CcSEcCtD
Tizanidine—Gastrointestinal pain—Topiramate—obesity	7.55e-05	0.000345	CcSEcCtD
Tizanidine—Urticaria—Topiramate—obesity	7.34e-05	0.000335	CcSEcCtD
Tizanidine—Abdominal pain—Topiramate—obesity	7.3e-05	0.000334	CcSEcCtD
Tizanidine—Body temperature increased—Topiramate—obesity	7.3e-05	0.000334	CcSEcCtD
Tizanidine—Hypersensitivity—Topiramate—obesity	6.81e-05	0.000311	CcSEcCtD
Tizanidine—Asthenia—Topiramate—obesity	6.63e-05	0.000303	CcSEcCtD
Tizanidine—Pruritus—Topiramate—obesity	6.53e-05	0.000299	CcSEcCtD
Tizanidine—Diarrhoea—Topiramate—obesity	6.32e-05	0.000289	CcSEcCtD
Tizanidine—Dizziness—Topiramate—obesity	6.11e-05	0.000279	CcSEcCtD
Tizanidine—Vomiting—Topiramate—obesity	5.87e-05	0.000268	CcSEcCtD
Tizanidine—Rash—Topiramate—obesity	5.82e-05	0.000266	CcSEcCtD
Tizanidine—Dermatitis—Topiramate—obesity	5.82e-05	0.000266	CcSEcCtD
Tizanidine—Nausea—Topiramate—obesity	5.49e-05	0.000251	CcSEcCtD
Tizanidine—ADRA2A—Signaling Pathways—PRL—obesity	8.38e-06	7.57e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PRKCD—obesity	8.37e-06	7.56e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SULT2A1—obesity	8.37e-06	7.56e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GLP1R—obesity	8.37e-06	7.56e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PIK3CB—obesity	8.33e-06	7.52e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—STK11—obesity	8.26e-06	7.46e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—LPL—obesity	8.25e-06	7.45e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—DPYD—obesity	8.23e-06	7.44e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CCL2—obesity	8.23e-06	7.43e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HTR2A—obesity	8.2e-06	7.4e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—C3—obesity	8.18e-06	7.39e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PLG—obesity	8.17e-06	7.38e-05	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—RHOA—obesity	8.16e-06	7.37e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—AKT2—obesity	8.08e-06	7.3e-05	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PIK3R1—obesity	8.07e-06	7.29e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GPX1—obesity	8.05e-06	7.27e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FOXO3—obesity	7.97e-06	7.2e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ADRB2—obesity	7.95e-06	7.18e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PRKAR2B—obesity	7.93e-06	7.16e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—DCN—obesity	7.87e-06	7.11e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CD36—obesity	7.84e-06	7.08e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SOCS1—obesity	7.83e-06	7.07e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PRKCD—obesity	7.82e-06	7.06e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IRS2—obesity	7.79e-06	7.03e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AGT—obesity	7.78e-06	7.02e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3CD—obesity	7.76e-06	7.01e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—AKT1—obesity	7.74e-06	6.99e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SOCS3—obesity	7.74e-06	6.99e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—obesity	7.73e-06	6.98e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CG—obesity	7.68e-06	6.94e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CPT1A—obesity	7.66e-06	6.91e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HTR2A—obesity	7.66e-06	6.91e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—C3—obesity	7.64e-06	6.9e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—LEP—obesity	7.62e-06	6.88e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—APOE—obesity	7.62e-06	6.88e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—GNB3—obesity	7.57e-06	6.84e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CAV1—obesity	7.55e-06	6.82e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—APOA1—obesity	7.53e-06	6.8e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—NAMPT—obesity	7.51e-06	6.78e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—TYK2—obesity	7.47e-06	6.74e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—obesity	7.46e-06	6.74e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—LIPC—obesity	7.46e-06	6.74e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GCK—obesity	7.46e-06	6.74e-05	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PIK3CB—obesity	7.45e-06	6.73e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IGF2—obesity	7.44e-06	6.72e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—MTHFR—obesity	7.43e-06	6.71e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—APOC3—obesity	7.41e-06	6.7e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PPARG—obesity	7.41e-06	6.69e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—RHOA—obesity	7.41e-06	6.69e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—GNAS—obesity	7.38e-06	6.66e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—obesity	7.36e-06	6.65e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3R1—obesity	7.33e-06	6.62e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—POMC—obesity	7.31e-06	6.6e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PPARA—obesity	7.29e-06	6.58e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—ESR1—obesity	7.27e-06	6.57e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IRS2—obesity	7.27e-06	6.57e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—INS—obesity	7.27e-06	6.57e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AGT—obesity	7.26e-06	6.56e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—AKT1—obesity	7.23e-06	6.53e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—APOB—obesity	7.22e-06	6.52e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CETP—obesity	7.2e-06	6.5e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—PIK3CA—obesity	7.19e-06	6.49e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—F2—obesity	7.18e-06	6.49e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PRKCB—obesity	7.18e-06	6.49e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SDC1—obesity	7.12e-06	6.43e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—LEP—obesity	7.12e-06	6.43e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—APOE—obesity	7.12e-06	6.43e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—BAD—obesity	7.1e-06	6.41e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—AGT—obesity	7.06e-06	6.37e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCL5—obesity	7.05e-06	6.37e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CAV1—obesity	7.05e-06	6.37e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—APOA1—obesity	7.04e-06	6.35e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—AKR1C3—obesity	7e-06	6.32e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—APOE—obesity	6.91e-06	6.24e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—LPL—obesity	6.9e-06	6.23e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SCARB1—obesity	6.89e-06	6.22e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CG—obesity	6.88e-06	6.21e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CAV1—obesity	6.85e-06	6.18e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FOXO1—obesity	6.85e-06	6.18e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—RPS6KB1—obesity	6.83e-06	6.17e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—APOA1—obesity	6.83e-06	6.17e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—obesity	6.8e-06	6.14e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IRS1—obesity	6.8e-06	6.14e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ESR1—obesity	6.79e-06	6.14e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3CB—obesity	6.77e-06	6.11e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CD—obesity	6.75e-06	6.1e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PRKCB—obesity	6.71e-06	6.06e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—F2—obesity	6.71e-06	6.06e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—obesity	6.71e-06	6.06e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SREBF1—obesity	6.69e-06	6.04e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—ALB—obesity	6.67e-06	6.02e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—BAD—obesity	6.63e-06	5.99e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—POMC—obesity	6.55e-06	5.91e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GOT2—obesity	6.51e-06	5.88e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—INS—obesity	6.51e-06	5.88e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CG—obesity	6.42e-06	5.8e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	6.42e-06	5.8e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CCL2—obesity	6.4e-06	5.78e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—NOS3—obesity	6.38e-06	5.76e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3R1—obesity	6.38e-06	5.76e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—FASN—obesity	6.37e-06	5.75e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PRKCD—obesity	6.35e-06	5.74e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IRS1—obesity	6.35e-06	5.73e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—BCHE—obesity	6.34e-06	5.73e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IGF1—obesity	6.3e-06	5.68e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AKT2—obesity	6.29e-06	5.68e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CG—obesity	6.24e-06	5.63e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HTR2A—obesity	6.22e-06	5.61e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—C3—obesity	6.21e-06	5.61e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP2E1—obesity	6.12e-06	5.53e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—POMC—obesity	6.11e-06	5.52e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—INS—obesity	6.08e-06	5.49e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—NQO1—obesity	6.05e-06	5.46e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CD—obesity	6.04e-06	5.46e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PPARG—obesity	6.02e-06	5.44e-05	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—PIK3CA—obesity	5.99e-06	5.41e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CCL2—obesity	5.98e-06	5.4e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—SERPINE1—obesity	5.98e-06	5.4e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—POMC—obesity	5.94e-06	5.36e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	5.93e-06	5.35e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IRS2—obesity	5.91e-06	5.33e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—INS—obesity	5.91e-06	5.33e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AGT—obesity	5.9e-06	5.33e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CB—obesity	5.89e-06	5.31e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IGF1—obesity	5.88e-06	5.31e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AKT2—obesity	5.88e-06	5.31e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—AKT1—obesity	5.87e-06	5.3e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	5.87e-06	5.3e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PTGS2—obesity	5.83e-06	5.27e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TYK2—obesity	5.82e-06	5.25e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GCG—obesity	5.8e-06	5.24e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SLC2A4—obesity	5.8e-06	5.24e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—APOE—obesity	5.78e-06	5.22e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—LEP—obesity	5.78e-06	5.22e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—RHOA—obesity	5.77e-06	5.21e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CAV1—obesity	5.73e-06	5.17e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYCS—obesity	5.73e-06	5.17e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—APOA1—obesity	5.71e-06	5.16e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NOS3—obesity	5.71e-06	5.15e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3R1—obesity	5.71e-06	5.15e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CD—obesity	5.65e-06	5.1e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GGT1—obesity	5.62e-06	5.07e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GOT1—obesity	5.62e-06	5.07e-05	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—PIK3CA—obesity	5.59e-06	5.05e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SERPINE1—obesity	5.58e-06	5.04e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—NCOA1—obesity	5.53e-06	5e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ESR1—obesity	5.52e-06	4.98e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CD—obesity	5.48e-06	4.95e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP19A1—obesity	5.46e-06	4.93e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—STK11—obesity	5.46e-06	4.93e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—F2—obesity	5.45e-06	4.92e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PRKCB—obesity	5.45e-06	4.92e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—PIK3CA—obesity	5.44e-06	4.91e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TYK2—obesity	5.43e-06	4.9e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ALB—obesity	5.41e-06	4.89e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—RHOA—obesity	5.39e-06	4.86e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—BAD—obesity	5.39e-06	4.86e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NOS3—obesity	5.33e-06	4.81e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3R1—obesity	5.33e-06	4.81e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CB—obesity	5.27e-06	4.76e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MTOR—obesity	5.27e-06	4.76e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CG—obesity	5.22e-06	4.71e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—NOS3—obesity	5.18e-06	4.68e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3R1—obesity	5.18e-06	4.68e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IRS1—obesity	5.16e-06	4.66e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PIK3CA—obesity	5.08e-06	4.59e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—COMT—obesity	5.07e-06	4.58e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PPARGC1A—obesity	5e-06	4.52e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GNB3—obesity	5e-06	4.52e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—HMOX1—obesity	4.98e-06	4.49e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—POMC—obesity	4.97e-06	4.48e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—INS—obesity	4.94e-06	4.46e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MTOR—obesity	4.92e-06	4.44e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CB—obesity	4.92e-06	4.44e-05	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—AKT1—obesity	4.89e-06	4.42e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GNAS—obesity	4.87e-06	4.4e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCL2—obesity	4.86e-06	4.39e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—IL6—obesity	4.81e-06	4.35e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CB—obesity	4.78e-06	4.32e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IGF1—obesity	4.78e-06	4.31e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AKT2—obesity	4.77e-06	4.31e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—APOB—obesity	4.77e-06	4.31e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PTGS2—obesity	4.74e-06	4.28e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CD—obesity	4.59e-06	4.14e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MMP9—obesity	4.58e-06	4.14e-05	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—AKT1—obesity	4.57e-06	4.13e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—LPL—obesity	4.55e-06	4.11e-05	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	4.54e-06	4.1e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SERPINE1—obesity	4.54e-06	4.1e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—IL6—obesity	4.5e-06	4.06e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MAPK8—obesity	4.45e-06	4.02e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GPX1—obesity	4.44e-06	4.01e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—AKT1—obesity	4.44e-06	4.01e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TYK2—obesity	4.41e-06	3.98e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—RHOA—obesity	4.38e-06	3.95e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3R1—obesity	4.33e-06	3.91e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NOS3—obesity	4.33e-06	3.91e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CD36—obesity	4.33e-06	3.91e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MMP9—obesity	4.28e-06	3.86e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MAPK8—obesity	4.16e-06	3.76e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—AKT1—obesity	4.15e-06	3.75e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3CA—obesity	4.13e-06	3.72e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—MTHFR—obesity	4.1e-06	3.7e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—STAT3—obesity	4.07e-06	3.68e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PPARA—obesity	4.02e-06	3.63e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CB—obesity	4e-06	3.61e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MTOR—obesity	4e-06	3.61e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—AGT—obesity	3.89e-06	3.52e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—APOE—obesity	3.82e-06	3.45e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—STAT3—obesity	3.8e-06	3.43e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MYC—obesity	3.78e-06	3.42e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CAV1—obesity	3.78e-06	3.41e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TGFB1—obesity	3.77e-06	3.41e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—APOA1—obesity	3.77e-06	3.41e-05	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—AKT1—obesity	3.71e-06	3.35e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—IL6—obesity	3.65e-06	3.3e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	3.61e-06	3.26e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CA—obesity	3.59e-06	3.24e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MYC—obesity	3.53e-06	3.19e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TGFB1—obesity	3.53e-06	3.18e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MMP9—obesity	3.47e-06	3.14e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CG—obesity	3.44e-06	3.11e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MAPK8—obesity	3.38e-06	3.05e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—AKT1—obesity	3.37e-06	3.04e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PPARG—obesity	3.32e-06	3e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—POMC—obesity	3.28e-06	2.96e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—INS—obesity	3.26e-06	2.94e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CA—obesity	3.21e-06	2.9e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—STAT3—obesity	3.09e-06	2.79e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CD—obesity	3.03e-06	2.73e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CA—obesity	3e-06	2.71e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALB—obesity	2.99e-06	2.7e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—AKT1—obesity	2.93e-06	2.65e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CA—obesity	2.91e-06	2.63e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MYC—obesity	2.87e-06	2.59e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TGFB1—obesity	2.86e-06	2.59e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3R1—obesity	2.86e-06	2.58e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—NOS3—obesity	2.86e-06	2.58e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IL6—obesity	2.84e-06	2.57e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IL6—obesity	2.66e-06	2.4e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CB—obesity	2.64e-06	2.38e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AKT1—obesity	2.62e-06	2.37e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PTGS2—obesity	2.61e-06	2.36e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AKT1—obesity	2.45e-06	2.21e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CA—obesity	2.44e-06	2.2e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—AKT1—obesity	2.38e-06	2.15e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IL6—obesity	2.16e-06	1.95e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AKT1—obesity	1.99e-06	1.8e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CA—obesity	1.61e-06	1.45e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—AKT1—obesity	1.31e-06	1.19e-05	CbGpPWpGaD
